UnknownNot Applicable

Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes

Canada60 participantsStarted 2019-09-01

Plain-language summary

This is a prospective comparative non-randomized cohort study to understand the long-term vision outcomes, safety, and stability of anterior chamber intraocular lenses (AC IOLs) vs. scleral-fixated intraocular lenses (SF IOLs).

Who can participate

Age range16 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients who are undergoing AC IOL or SF IOL implantation for any reason (including but not limited to aphakia, posterior capsular rupture, primary or secondary lens dislocation/ subluxation or IOL exchange).
✓. Patients on whom imaging (specular microscopy, biometry and OCT) can be performed without delaying their treatment (i.e. based on availability of operator).
✓. Decision makers able to provide informed consent.

Exclusion criteria

✕. Inability to obtain adequate imaging, in the form of specular microscopy and OCT data at baseline.
✕. Patients unable to attend follow-up visits.
✕. Patients who have had a corneal transplant prior to secondary IOL implantation.

What they're measuring

Endothelial cell loss

Timeframe: Pre-operative (baseline) and 24 weeks post-operatively.

Trial details

NCT IDNCT04072978

SponsorSunnybrook Health Sciences Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-30

Contact for this trial

Cindy Rutz

416 480 5091 cindy.rutz@sunnybrook.ca

View on ClinicalTrials.gov More Corneal Endothelial Cell Loss trials